A comprehensive review of exceptional responders to anticancer drugs in the biomedical literature.

Main|Search|PHGKB

CDC’s Bring Your Brave campaign provides information about breast cancer to women younger than age 45 by sharing real stories about young women whose lives have been affected by breast cancer.

Last Posted: Aug 02, 2018

---

• A comprehensive review of exceptional responders to anticancer drugs in the biomedical literature.
  Nishikawa Go et al. European journal of cancer (Oxford, England : 1990) 2018 Jul 101143-151
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
  Vos Shoko et al. Critical reviews in oncology/hematology 2018 Jul 12729-41
• Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
  Schwartzberg Barbara S et al. American journal of surgery 2018 Jul
• Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
  Sparano Joseph et al. JAMA oncology 2018 Jul
• BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
  Kowalik Artur et al. PloS one 2018 13(7) e0201086
• Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling.
  Di Mattei Valentina E et al. Frontiers in psychology 2018 91218
• DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes.
  Richardson Marcy E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul
• International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.
  Hartmann Hali et al. Chinese journal of cancer 2017 Nov 36(1) 92
• Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer.
  Hertz D L et al. The pharmacogenomics journal 2017 Dec 17(6) 521-527
• Precision medicine in breast cancer.
  Naito Yoichi et al. Chinese clinical oncology 2018 Jun 7(3) 29

more